B3GNT5 is pivotal in the biosynthesis of lactosylceramide sphingolipids and regulates embryonic antigens with lacto-series carbohydrate structures, suggesting its role as a biomarker in various tumours (Kim and Koo, 2019). Here, B3GNT5 is linked to neoplasm.